Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Brandi Z. Murrain
    • Rachel N. Lugay
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

DOJ Announces First Civil Settlement Alleging PPP Fraud

Jan 15, 2021 | COVID-19 Related Law, False Claims Act, Fraud Investigations

In April 2020, CG attorneys wrote about the increased risk of government scrutiny for recipients of the CARES Act Paycheck Protection Program (PPP), which initially provided over $349 billion in forgivable PPP loans to small businesses. As Congress authorized hundreds...

Second Drug Manufacturer and Vendor Settles False Claims Act Allegations Related to Co-pay Coverage

Dec 22, 2020 | False Claims Act

In July 2020, CG attorneys discussed two settlements by Novartis Pharmaceuticals Corporation for $729 million involving allegations that Novartis paid kickbacks to doctors and patients.  One settlement involved Novartis agreeing to pay $51.25 million to resolve...

HHS Continues Cross-Agency Collaborations with New FCA Working Group

Dec 10, 2020 | False Claims Act

On December 4, 2020, the U.S. Department of Health and Human Services (HHS) announced the creation of the False Claims Act Working Group (FCA Working Group).  The federal False Claims Act (FCA) has remained one of the federal government’s top tools to investigate and...

False Claims Act: D.C. District Court Judge Rules that Whistleblowers Alleging Fraud in the Inducement Need Not Allege Materiality

Dec 2, 2020 | False Claims Act

On November 6, 2020, a D.C. District Court judge ruled that a whistleblower bringing a suit under the False Claims Act (FCA) need not allege “materiality” when relying on the “fraud in the inducement” theory of falsity.  Over the years, Congress and federal agencies...

False Claims Act: Will the U.S. Supreme Court Define “Falsity”?

Nov 20, 2020 | False Claims Act, Fraud Investigations, Government Investigations, Medicare and Medicaid

The federal False Claims Act (FCA) imposes liability for treble damages and civil penalties on “any person who [among other things] … knowingly presents, or causes to be presented, a false or fraudulent claim for payment” to the federal government or who...

Chicago Charter School Chain Pays $4.5 Million to Resolve False Claims Act Allegations

Nov 11, 2020 | False Claims Act, Fraud Investigations, Government Investigations

A chain of charter schools based in Chicago has agreed to pay a $4.5 million civil fine to close a federal corruption investigation that first came into public view in June 2014. In its statement announcing the settlement, the U.S. Department of Justice (DOJ) accused...
« Older Entries
Next Entries »

Recent Posts

  • The Rebirth of the DOJ’s False Claims Act Working Group
  • When ICE Crosses the Line, What Can Be Done?
  • Chilivis Grubman Secures Important Election Law Victory at Georgia Court of Appeals
  • Medicare Audits: How Long Does Medicare Have to Reopen Claims?
  • Tech Square Phase 3: How Georgia Tech Is Reshaping Midtown Through Strategic Land Use

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Civil Rights
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group